NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Virus Weekly


New findings from K.J. Szretter and co-authors in the area of influenza published



*
Virus Weekly Library
Library Home

This article was published in Virus Weekly, which you can subscribe to online.

NewsRx
NewsRx
2009 JUL 14 - (NewsRx.com) -- According to recent research published in the Journal of Virology, "Widespread distribution of highly pathogenic avian H5N1 influenza viruses in domesticated and wild birds continues to pose a threat to public health, as interspecies transmission of virus has resulted in increasing numbers of human disease cases. Although the pathogenic mechanism(s) of H5N1 influenza viruses has not been fully elucidated, it has been suggested that the ability to evade host innate responses, such as the type I interferon response, may contribute to the virulence of these viruses in mammals."

"We investigated the role that type I interferons (alpha/beta interferon [IFN-alpha/beta]) might play in H5N1 pathogenicity in vivo, by comparing the kinetics and outcomes of H5N1 virus infection in IFN-alpha/beta receptor (IFN-alpha/beta R)-deficient and SvEv129 wild-type mice using two avian influenza A viruses isolated from humans, A/Hong Kong/483/97 (HK/483) and A/Hong Kong/486/97 (HK/486), which exhibit high and low lethality in mice, respectively. IFN-alpha/beta R-deficient mice experienced significantly more weight loss and more rapid time to death than did wild-type mice. HK/486 virus caused a systemic infection similar to that with HK/483 virus in IFN-alpha/beta R-deficient mice, suggesting a role for IFN-alpha/beta in controlling the systemic spread of this H5N1 virus. HK/483 virus replicated more efficiently than HK/486 virus both in vivo and in vitro. However, replication of both viruses was significantly reduced following pretreatment with IFN-alpha/beta," wrote K.J. Szretter and colleagues.

The researchers concluded: "These results suggest a role for the IFN-alpha/beta response in the control of H5N1 virus replication both in vivo and in vitro, and as such it may provide some degree of protection to the host in the early stages of infection."

Szretter and colleagues published their study in the Journal of Virology (Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice. Journal of Virology, 2009;83(11):5825-5834).

For additional information, contact J.M. Katz, Center Diseases Control & Prevention, Influenza Division, National Center Immunizat & Respiratory Diseases, MS G-16, 1600 Clifton Rd., Atlanta, GA 30333, USA.

The publisher's contact information for the Journal of Virology is: American Society Microbiology, 1752 N St. NW, Washington, DC 20036-2904, USA.

Keywords: United States, Atlanta, Avian Flu, Avian Influenza, Bird Flu, Influenza Virus, Interferon, Public Health, Viral Research, Virology.

This article was prepared by Virus Weekly editors from staff and other reports. Copyright 2009, Virus Weekly via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login